SPERM.ST
Price:
$0.0064
Market Cap:
$19.35M
Spermosens AB engages in the research, development, and commercialization of diagnostic technology in health and medical care in Sweden. The company provides male infertility fertility diagnostics and fertility treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. The company was incorporated in 2018 and is based in Lund, Sweden.
Industry
Medical - Diagnostics & Research
IPO Date
2021-05-19
Stock Exchange
STO
Ticker
SPERM.ST
According to Spermosens AB’s latest financial reports and current stock price. The company's current ROE is -27.91%. This represents a change of 292.09% compared to the average of -7.12% of the last 4 quarters.
The mean historical ROE of Spermosens AB over the last ten years is -72.90%. The current -27.91% ROE has changed -61.72% with respect to the historical average. Over the past ten years (40 quarters), SPERM.ST's ROE was at its highest in in the June 2020 quarter at 0%. The ROE was at its lowest in in the December 2020 quarter at -42.22%.
Average
-72.90%
Median
-48.56%
Minimum
-216.95%
Maximum
0%
Discovering the peaks and valleys of Spermosens AB ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 698.42%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -216.95%
| Year | ROE | Change |
|---|---|---|
| 2024 | -37.32% | -61.19% |
| 2023 | -96.14% | -55.69% |
| 2022 | -216.95% | 698.42% |
| 2021 | -27.17% | -54.56% |
| 2020 | -59.80% | -Infinity% |
The current ROE of Spermosens AB (SPERM.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-116.80%
5-year avg
-87.47%
10-year avg
-72.90%
Spermosens AB’s ROE is greater than Prostatype Genomics AB (publ) (-129.53%), greater than Aptahem AB (publ) (-11.60%), greater than Fluicell AB (publ) (-45.98%), greater than ODI Pharma AB (-918.08%), greater than Chordate Medical Holding AB (publ) (-173.23%), greater than Stayble Therapeutics AB (publ) (-103.16%), greater than Episurf Medical AB (publ) (-95.80%), greater than Quia Pharma AB (publ) (-315.23%), greater than S2Medical AB (publ) (-21.20%), less than Qlife Holding AB (publ) (800.38%),
| Company | ROE | Market cap |
|---|---|---|
| -129.53% | $20.77M | |
| -11.60% | $16.98M | |
| -45.98% | $14.56M | |
| -918.08% | $30.98M | |
| -173.23% | $1.49M | |
| -103.16% | $16.38M | |
| -95.80% | $21.93M | |
| -315.23% | $2.36M | |
| -21.20% | $9.03M | |
| 800.38% | $19.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spermosens AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Spermosens AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Spermosens AB's ROE?
How is the ROE calculated for Spermosens AB (SPERM.ST)?
What is the highest ROE for Spermosens AB (SPERM.ST)?
What is the 3-year average ROE for Spermosens AB (SPERM.ST)?
What is the 5-year average ROE for Spermosens AB (SPERM.ST)?
How does the current ROE for Spermosens AB (SPERM.ST) compare to its historical average?